SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving attention, with traders pointing to leveraged long liquidations and broader risk-off pressure. The community is split between buying an oversold dip near technical support and expecting further declines if selling continues.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial of GPS has reached the 80th event, and the company expects topline results this month, driving intense attention ahead of the AML data readout. Traders celebrated a sharp after-hours move and speculated about a data leak or short covering, while others cautioned that the trial remains blinded and its outcome is unknown.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints from users whose work was interrupted. Traders debated whether the prolonged disruption should pressure the stock, which held near flat-to-positive, while some speculated about a cyberattack without confirmation.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to risk-off sentiment, inflation and rate-hike concerns, and leveraged liquidations. The steep decline has sparked debate over whether support will hold or losses will deepen, while some holders are buying the dip and others cite stalled regulatory progress and weak demand as reasons for caution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure alongside Bitcoins slide and broader weakness in crypto-linked stocks, with traders highlighting fresh lows and arguing over whether the selloff has further to run or the shares are forming a base. Some also point to COINs underperformance versus Bitcoin and concerns about trading activity, while a smaller group sees an oversold bounce opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention amid weakness in Ethereum and broader crypto-linked stocks, with traders focused on its ETH-treasury exposure and the shares decline. The community is split between dip-buyers expecting a recovery and critics questioning Tom Lees strategy, company spending, transparency and buybacks.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tatva Chintan Enters New Growth Cycle With EURO 7, Agro Push: SEBI RA Rajneesh Sharma

Equity

The analyst sees potential for a sharp FY26 turnaround and a medium-term re-rating.

Tatva Chintan Pharma Chem Ltd. is a chemicals manufacturing company. The firm is engaged in the manufacture of portfolio, which includes structure directing agents(SDAs), phase transfer catalysts(PTCs), electrolyte salts for super capacitor batteries, and pharmaceutical and agrochemical intermediates and other specialty chemicals(PASC). The company was founded on June 12, 1996 and is headquartered in Vadodara, India.

Tatva Chintan Pharma Chem Ltd.

Bearish Sentiment

Tatva Chintan has broken out of a 1.5-year downtrend, both technically and fundamentally, suggesting the start of a new growth cycle, according to SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/Rajneesh_Sharma_Official">Rajneesh Sharma</a>.<stembedurl>https://stocktwits.com/Rajneesh_Sharma_Official/message/617166023</stembedurl>At the time of writing,&nbsp;<a href="https://stocktwits.com/symbol/TATVA.NSE">Tatva Chintan shares</a> were trading at ₹939.65, up ₹6.9 or 0.7% on the day.He highlights the upcoming EURO 7 emission standards as a structural growth driver, with light-duty vehicles affected from July 2025 and heavy-duty from July 2027.&nbsp;This will increase catalyst requirements by 2.8 times per vehicle. Tatva is estimated to capture $15–22 million of the incremental Solvent Deasphalting Agent (SDA) total addressable market, with the ramp starting in the third quarter (Q3).Sharma also points to the company’s global-first alternate synthesis route for an agrochemical molecule as a new high-margin growth pillar, with bulk orders secured and commercial shipments planned for Q3.&nbsp;The management expects combined agrochemical and SDA growth of 40–70% in FY26. Additional growth levers include electrolyte salts, which are expected to grow 2–3 times from the first quarter (Q1), and four pharma intermediates currently in validation or commercial supply.On guidance, Sharma said FY26 revenue is expected to grow over 25% year-on-year, with core profit margins expanding from 9% to 20%.&nbsp;He identified key milestones, including electrolyte salts and initial SDA volumes in Q1, followed by full SDA and agrochemical molecule ramp in Q3.From a technical perspective, Sharma confirms that the long-term downtrend channel since late 2022 has been decisively broken, with the ₹825–850 resistance level now acting as strong support.&nbsp;He noted a bullish RSI divergence, with the relative strength index (RSI) at 62.63, indicating momentum without overbought conditions.&nbsp;The breakout occurred on volume of about 2 million shares, versus an average of 25,500, suggesting institutional accumulation.On valuation, Sharma notes FY25 revenue was flat and profit-after-tax sharply lower, but FY26 is poised for sharp revenue and margin expansion, making Tatva a re-rating candidate.&nbsp;He identified risks, including the pace of the adoption of EURO 7, the commissioning of the PASC plant, and commodity volatility affecting SDA margins.Sharma said that Tatva Chintan could be entering a new cycle driven by EURO 7 and the agrochemical molecule. It has strong support at ₹825–850 and medium-term price targets of ₹1,250–₹1,300 over 12 to 18 months.&nbsp;He advised investors to watch SDA volumes in Q3, agrochemical molecule scaling, and margin improvement toward 20% core profit.On Stocktwits, retail sentiment was ‘bullish’ amid ‘normal’ message volume.The stock has risen 9.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Current Price	1,666.60
Prev Close	1,662.00
Open	1,670.00
Dividend Yield	0.19%
50-Day Moving Average	1,731.40
Beta	N/A
Avg. Volume	144,138.86
PE Ratio	61.71

52-Week High	2,113.60
52-Week Low	1,044.10
Market Capitalization	38.64B
EPS (Annual)	17.98
Price to Book	4.77
Revenue Per Employee	4.59M

Feed

News

Sentiment

Fundamentals

Info

TATVA.NSE Fundamentals